World's Best Scientists 2026 revealed!
Axel Heidenreich

Axel Heidenreich

D-Index & Metrics

Medicine

D-Index
92
Citations
45259
World Ranking
11099
National Ranking
601

Overview

Axel Heidenreich is affiliated with the University of Cologne in Germany and has contributed extensively to the field of medicine, with a particular focus on pulmonary and respiratory medicine, surgery, rheumatology, molecular biology, and oncology. Their research portfolio includes significant work on prostate cancer treatment and research, prostate cancer diagnosis and treatment, testicular diseases and treatments, bladder and urothelial cancer treatments, urologic and reproductive health conditions, sarcoma diagnosis and treatment, and genital health and disease.

The scientist has published numerous papers in notable venues, including:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • European Urology
  • European Urology Open Science
  • British Journal of Urology

Frequent coauthors associated with Axel Heidenreich's work include David Pfister, Pia Paffenholz, Tim Nestler, Alberto Briganti, and Peter Albers.

Selected recent publications include:

  • "Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2020, Annals of Oncology
  • "Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration," 2020, Journal of Clinical Oncology
  • "Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019," 2020, European Urology
  • "Rucaparib or Physician's Choice in Metastatic Prostate Cancer," 2023, New England Journal of Medicine
  • "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium," 2021, Journal of Clinical Oncology

Axel Heidenreich's research has primarily focused on clinical and translational aspects of urologic cancers, with a strong emphasis on prostate and testicular cancers. The scope of their research also reaches into cancer therapeutics and guidelines, reflecting involvement in shaping clinical practice and treatment protocols.

The main fields of study attributed to this scientist are medicine and oncology, with their work bridging molecular biology and surgical interventions. Their body of research spans both diagnosis and treatment approaches, addressing complex urologic and reproductive health challenges.

Best Publications

  • EAU guidelines on prostate cancer

    Axel Heidenreich;Gunnar Aus;Michel Bolla;Steven Joniau

  • EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

    Axel Heidenreich;Patrick J. Bastian;Joaquim Bellmunt;Michel Bolla

  • EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

    Axel Heidenreich;Joaquim Bellmunt;Michel Bolla;Steven Joniau

  • EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer ☆

    Nicolas Mottet;Joaquim Bellmunt;Michel Bolla;Steven Joniau

  • 前立腺癌のEAUガイドライン。パート1:臨床的限局性疾患のスクリーニング,診断および治療

    A Heidenreich;J Bellmunt;M Bolla;S Joniau

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.: Annals of oncology : official journal of the European Society for Medical Oncology

    C. Parker;E. Castro;K. Fizazi;A. Heidenreich

  • Guidelines on Prostate Cancer

    A. Heidenreich;J. Bellmunt;M. Bolla;S. Joniau

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Silke Gillessen;Gerhardt Attard;Tomasz M Beer;Himisha Beltran

  • Pelvic Lymph Node Dissection in Prostate Cancer

    Alberto Briganti;Michael L. Blute;James H. Eastham;Markus Graefen

  • Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration.

    Wassim Abida;Akash Patnaik;David Campbell;Jeremy Shapiro

  • Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    C. Parker;S. Gillessen;A. Heidenreich;A. Horwich

  • ICUD-EAU international consultation on bladder cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder

    Georgios Gakis;Jason Efstathiou;Seth P. Lerner;Michael S. Cookson

  • Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy

    Axel Heidenreich;Carsten H. Ohlmann;Sergej Polyakov

  • Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group

    Peter Albers;Roswitha Siener;Susanne Krege;Hans-Uwe Schmelz

  • Risk Factors for Relapse in Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: Results of the German Testicular Cancer Study Group Trial

    Peter Albers;Roswitha Siener;Sabine Kliesch;Lothar Weissbach

  • Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Matthew Smith;Chris Parker;Fred Saad;Kurt Miller

  • Guía de la EAU sobre el cáncer de próstata: Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castración

    N. Mottet;Joaquim Bellmunt;M. Bolla;S. Joniau

  • EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer - Guía de la EAU sobre el cáncer de próstata. Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castración

    N. Mottet;J. Bellmunt;M. Bolla;S. Joniau

Frequent Co-Authors

David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Peter Albers
Peter Albers Heinrich Heine University Düsseldorf
Silke Gillessen
Silke Gillessen Universita della Svizzera Italiana
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Fred Saad
Fred Saad University of Montreal
Steven Joniau
Steven Joniau KU Leuven
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Kurt Miller
Kurt Miller Charité - University Medicine Berlin
Karim Fizazi
Karim Fizazi University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA opens diverse online education and advancement opportunities. While medical school remains the cornerstone for physicians, many students explore related pathways such as healthcare administration, nursing, and pharmacy for flexibility and impactful roles.

For those interested in management and leadership, exploring the cheapest mha programs online and the most affordable mha programs is a great way to discover cost-effective ways to earn a Master’s in Healthcare Administration (MHA). These programs prepare graduates for leadership roles in hospitals, clinics, and public health organizations.

Nurses hoping to advance their clinical expertise can benefit from a 1 year dnp program online, helping them fast-track their careers in advanced practice, education, or leadership.

Meanwhile, future pharmacists have options to compare online pharmacy school cost, making it easier to enter this rewarding healthcare field affordably.

By considering these related degrees, students can tailor their education to align with their career goals, timelines, and budgets without compromising on quality.

Best Scientists Citing Axel Heidenreich

Trending Scientists